These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

114 related articles for article (PubMed ID: 16530290)

  • 1. Alterations of leptin during IFN-alpha therapy in patients with chronic viral hepatitis.
    Zografos TA; Rigopoulou EI; Liaskos C; Togousidis E; Zachou K; Gatselis N; Germenis A; Dalekos GN
    J Hepatol; 2006 May; 44(5):848-55. PubMed ID: 16530290
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Adiponectin: a new independent predictor of liver steatosis and response to IFN-alpha treatment in chronic hepatitis C.
    Zografos TA; Liaskos C; Rigopoulou EI; Togousidis E; Makaritsis K; Germenis A; Dalekos GN
    Am J Gastroenterol; 2008 Mar; 103(3):605-14. PubMed ID: 18190648
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Serum adipokine levels in chronic liver diseases: association of resistin levels with fibrosis severity.
    Tsochatzis E; Papatheodoridis GV; Hadziyannis E; Georgiou A; Kafiri G; Tiniakos DG; Manesis EK; Archimandritis AJ
    Scand J Gastroenterol; 2008; 43(9):1128-36. PubMed ID: 18609175
    [TBL] [Abstract][Full Text] [Related]  

  • 4. An assessment of serum leptin levels in patients with chronic viral hepatitis: a prospective study.
    Manolakopoulos S; Bethanis S; Liapi C; Stripeli F; Sklavos P; Margeli A; Christidou A; Katsanika A; Vogiatzakis E; Tzourmakliotis D; Theocharis S
    BMC Gastroenterol; 2007 May; 7():17. PubMed ID: 17540037
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Chronic hepatitis C virus infection in renal transplant: treatment and outcome.
    Sharma RK; Bansal SB; Gupta A; Gulati S; Kumar A; Prasad N
    Clin Transplant; 2006; 20(6):677-83. PubMed ID: 17100715
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Successful application of highly purified natural interferon alpha (multiferon) in a chronic hepatitis C patient resistant to preceding treatment approaches.
    Musch E; Malek M; von Eick H; Chrissafidou A
    Hepatogastroenterology; 2004; 51(59):1476-9. PubMed ID: 15362781
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Autoantibodies in children with chronic hepatitis B infection and the influence of interferon alpha.
    Kansu A; Kuloğlu Z; Demirçeken F; Girgin N
    Turk J Gastroenterol; 2004 Dec; 15(4):213-8. PubMed ID: 16249973
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Natural anticoagulants and fibrinolytic activity following interferon therapy in chronic viral hepatitis.
    Al Ghumlas AK; Abdel Gader AG; Al Faleh FZ
    Blood Coagul Fibrinolysis; 2008 Jun; 19(4):263-7. PubMed ID: 18469546
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Early decrease in serum IV-7S levels during IFN treatment predicts anti-fibrogenic effect in nonresponders with chronic hepatitis C.
    Abe S; Narita R; Hiura M; Jia DM; Tabaru A; Otsuki M
    J Gastroenterol; 2004; 39(3):247-54. PubMed ID: 15065002
    [TBL] [Abstract][Full Text] [Related]  

  • 10. [Characteristics of the cytokine profile and peripheral blood lymphocyte subpopulations in patients with chronic viral hepatitis B and C in comparison to severity of morphological changes of the liver].
    Lazareva AS; Volchkova EV; Umbetova KT; Chulanov VP; Parkhomenko IuG; Kiselevskiĭ MV; Pak SG
    Ter Arkh; 2009; 81(4):55-60. PubMed ID: 19514423
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Demonstration of an association between detection of IgG antibody reactivity towards the C-terminal region of the preS1 protein of hepatitis B virus and the capacity to respond to interferon therapy in chronic hepatitis B.
    Hellström U; Lindh M; Krogsgaard K; Sylvan S
    J Gastroenterol Hepatol; 2008 May; 23(5):804-10. PubMed ID: 17931371
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Comparison of interferon and lamivudine treatment in Japanese patients with HBeAg positive chronic hepatitis B.
    Arase Y; Ikeda K; Suzuki F; Suzuki Y; Kobayashi M; Akuta N; Hosaka T; Sezaki H; Yatsuji H; Kawamura Y; Kobayashi M; Kumada H
    J Med Virol; 2007 Sep; 79(9):1286-92. PubMed ID: 17607775
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Enhanced expression of suppressor of cytokine signalling-1 in the liver of chronic hepatitis C: possible involvement in resistance to interferon therapy.
    Imanaka K; Tamura S; Fukui K; Ito N; Kiso S; Imai Y; Naka T; Kishimoto T; Kawata S; Shinomura Y;
    J Viral Hepat; 2005 Mar; 12(2):130-8. PubMed ID: 15720527
    [TBL] [Abstract][Full Text] [Related]  

  • 14. [Study of the relapse of patients with chronic hepatitis B undergoing first and repeated recombinant interferon-alpha therapy during long-term follow up].
    Liu DL; Luo KX; Feng XR; Fu QX; Hou JL
    Zhonghua Yi Xue Za Zhi; 2007 Jul; 87(26):1840-3. PubMed ID: 17922996
    [TBL] [Abstract][Full Text] [Related]  

  • 15. [Role of neutralizing anti-interferon antibodies during interferon therapy in patients with chronic hepatitis B].
    Wang YP
    Zhonghua Shi Yan He Lin Chuang Bing Du Xue Za Zhi; 2009 Aug; 23(4):304-6. PubMed ID: 20108781
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Study on the function of circulating plasmacytoid dendritic cells in the immunoactive phase of patients with chronic genotype B and C HBV infection.
    Wang K; Fan X; Fan Y; Wang B; Han L; Hou Y
    J Viral Hepat; 2007 Apr; 14(4):276-82. PubMed ID: 17381720
    [TBL] [Abstract][Full Text] [Related]  

  • 17. A sustained virological response to interferon or interferon/ribavirin reduces hepatocellular carcinoma and improves survival in chronic hepatitis C: a nationwide, multicentre study in Taiwan.
    Yu ML; Lin SM; Chuang WL; Dai CY; Wang JH; Lu SN; Sheen IS; Chang WY; Lee CM; Liaw YF
    Antivir Ther; 2006; 11(8):985-94. PubMed ID: 17302368
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Response to interferon-alpha in chronic hepatitis B patients with and without precore mutant strain and effects on HBsAg titers.
    Akhan SC; Yulugkural Z; Vahaboglu H
    Chemotherapy; 2007; 53(6):402-6. PubMed ID: 17934260
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Treatment with alpha-interferon in chronic hepatitis.
    Matei I; Tănăsescu C; Voiosu R; Murariu E; Dragomir P; Serbănescu A
    Rom J Intern Med; 1998; 36(3-4):227-37. PubMed ID: 10822519
    [TBL] [Abstract][Full Text] [Related]  

  • 20. [Cytokine spectrum in patients with chronic hepatitis C in the treatment with interferon-alpha drugs].
    Sobchak DM; Korochkina OV; Monakova EA
    Ter Arkh; 2005; 77(2):70-2. PubMed ID: 15807457
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 6.